13063_2023_7726_MOESM1_ESM.docx (26.45 kB)
Additional file 1 of The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}
journal contribution
posted on 2023-11-29, 04:42 authored by Mengzhuo Xu, Xin Zhang, Runyu Ye, Xueting Liu, Lirong Sun, Shanshan Jia, Zhipeng Zhang, Xinran Li, Ziqiong Wang, Hang Liao, Rufeng Shi, Kai Liu, Si Wang, Qingtao Meng, Xiaoping ChenAdditional file 1. Reporting checklist for protocol of a clinical trial.
Funding
Nanjing Chia Tai Tianqing Pharmaceutical Co. LTD
History
Usage metrics
Keywords
http :// www6 – 1010 may 2022ambulatory blood pressuretrial registration chictr2200059719whether antihypertensive medicationmoderate essential hypertensionnocturnal blood pressurelabel clinical trialblood pressureantihypertensive medicationclinical trialclinical practiceweek intervalsundergo 24uncontrolled hypertensionstill uncontrolledsecondary objectivesrandomly assignedprimary objectivepresently underwaynocturnal reductionnew directionmg tabletincidence rateeffective controlcircadian rhythmcardiovascular diseaseadjusted according2 tablets
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC